Phibro Animal Health Corp (PAHC) stock
PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3047% below fair value
$33.29−0.79 (-2.32%)
Close on Nov 20, 2026Market cap $1.35BP/E 13.7Yield 1.44%
Phibro Animal Health free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Phibro Animal Health's free cash flow for the twelve months ending Jun 30, 2026 was $9.87M, down 76.4% year over year. For fiscal 2026 it was $9.87M, down 76.4% from the year before. Over ten years it grew 27.5% a year on average. The highest annual figure on record is $77.51M in fiscal 2017.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $9.87M | -76.4% |
| FY2025 | Jun 30, 2025 | $41.83M | -9.8% |
| FY2024 | Jun 30, 2024 | $46.36M | – |
| FY2023 | Jun 30, 2023 | -$38.48M | – |
| FY2022 | Jun 30, 2022 | -$5.40M | -128.4% |
| FY2021 | Jun 30, 2021 | $18.99M | -25.0% |
| FY2020 | Jun 30, 2020 | $25.30M | +46.4% |
| FY2019 | Jun 30, 2019 | $17.28M | -66.4% |
| FY2018 | Jun 30, 2018 | $51.46M | -33.6% |
| FY2017 | Jun 30, 2017 | $77.51M | +8849.8% |
| FY2016 | Jun 30, 2016 | $866.00K | -98.2% |
| FY2015 | Jun 30, 2015 | $48.65M | – |
| FY2014 | Jun 30, 2014 | -$20.56M | – |
| FY2013 | Jun 30, 2013 | -$18.51M | -207.8% |
| FY2012 | Jun 30, 2012 | $17.16M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $5.23M | -35.7% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $890.00K | -97.5% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $8.26M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$4.50M | -248.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $8.13M | -47.1% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $35.41M | +2011.4% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$4.75M | -123.0% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $3.04M | -65.2% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $15.36M | +64.3% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $1.68M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $20.60M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $8.72M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $9.35M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$1.65M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$12.31M | -199.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$33.87M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$10.32M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$3.88M | -142.5% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $12.43M | -36.6% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$3.63M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$4.02M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $9.14M | -52.2% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $19.60M | -17.1% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$5.72M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$6.20M | -230.2% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $19.10M | +138.8% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $23.65M | +154.6% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$11.25M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $4.76M | +4.0% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $8.00M | -57.1% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $9.29M | -67.3% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$4.77M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $4.58M | -43.3% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $18.64M | -42.2% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $28.44M | +31.5% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$195.00K | -101.3% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $8.07M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $32.26M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $21.62M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $15.55M | – |
See a number that looks wrong?